Author

Nathaniel Katz

Analgesic Solutions, Tufts University - Cited by 22,878 - pain - opioids

Biography

Dr.  Nathaniel Katz is an Associate professor in the Department of Anesthesiology, Analgesic Solutions, Natick, Tufts University School of Medicine, Boston,  USA. and his study interests major on emerging or re-emerging disease and the microbes-host interaction. In recent years, he has studied several viruses including HIV-1, human or avian influenza, dengue, and Zika viruses. Currently, Dr. Nathaniel Katz is the author/editor/reviewer in several international journals. He published 4 articles in many journals and the articles are informative and got good citations
Title
Cited by
Year
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
RR Edwards, RH Dworkin, DC Turk, MS Angst, R Dionne, R Freeman, ...Pain Reports 6 (1), 2021202
303
2021
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations
JS Gewandter, J Brell, G Cavaletti, PM Dougherty, S Evans, L Howie, ...Neurology 91 (9), 403-413, 2018201
64
2018
Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials
DS Meske, OD Lawal, H Elder, V Langberg, F Paillard, N KatzJournal of pain research, 923-934, 2018201
64
2018
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations
SM Smith, RH Dworkin, DC Turk, M McDermott, C Eccleston, JT Farrar, ...Pain 161 (11), 2446, 2020202
54
2020
Accurate pain reporting training diminishes the placebo response: results from a randomised, double-blind, crossover trial
R Treister, OD Lawal, JD Shecter, N Khurana, J Bothmer, M Field, ...PLoS One 13 (5), e0197844, 2018201
39
2018
A deeper look at pain variability and its relationship with the placebo response: results from a randomized, double-blind, placebo-controlled clinical trial of naproxen in …
R Treister, L Honigman, OD Lawal, RK Lanier, NP KatzPain 160 (7), 1522-1528, 2019201
37
2019
NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain
P Arsenault, D Chiche, W Brown, J Miller, R Treister, R Leff, P Walker, ...Pain Reports 3 (6), 2018201
36
2018
Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations
JS Gewandter, RH Dworkin, DC Turk, EG Devine, D Hewitt, MP Jensen, ...The Journal of Pain 21 (9-10), 931-942, 2020202
36
2020
Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials …
N Katz, RH Dworkin, R North, S Thomson, S Eldabe, SM Hayek, ...Pain 162 (7), 1935, 2021202
29
2021
Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis
KV Patel, R Allen, L Burke, JT Farrar, JS Gewandter, I Gilron, NP Katz, ...Pain 159 (11), 2245, 2018201
29
2018
Composite outcomes for pain clinical trials: considerations for design and interpretation
JS Gewandter, MP McDermott, S Evans, NP Katz, JD Markman, LS Simon, ...Pain 162 (7), 1899, 2021202
27
2021
Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial
J Markman, M Resnick, S Greenberg, N Katz, R Yang, J Scavone, ...Journal of neurology 265, 2815-28, 2018201
24
2018
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain
J Markman, J Gudin, R Rauck, C Argoff, M Rowbotham, E Agaiby, ...Pain 160 (6), 1374, 191
20
2019
Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical …
JS Gewandter, SM Smith, RH Dworkin, DC Turk, TJ Gan, I Gilron, S Hertz, ...Pain 162 (11), 2669-2681, 2021202
18
2021
Navigating trials of personalized pain treatments: We’re going to need a bigger boat.
JS Gewandter, MP McDermott, O Mbowe, RR Edwards, NP Katz, DC Turk, ...Pain 0 (6), 1235, 2019201
16
2019
Design and conduct of confirmatory chronic pain clinical trials
N KatzPain reports 6 (1), 2021202
16
2021
Systematic review of research methods and reporting quality of randomized clinical trials of spinal cord stimulation for pain
E McNicol, MK Ferguson, K Bungay, EL Rowe, S Eldabe, JS Gewandter, ...The Journal of Pain 22 (2), 127-2, 2021202
14
2021
Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis
S As-Sanie, AM Soliman, K Evans, N Erpelding, R Lanier, NP KatzJournal of Medical Economics 23 (4), 371-377, 2020202
14
2020
Demonstrating heterogeneity of treatment effects among patients: an overlooked but important step toward precision medicine
JS Gewandter, MP McDermott, H He, S Gao, X Cai, JT Farrar, NP Katz, ...Clinical Pharmacology & Therapeutics 106 (1), 204-210, 2019201
14
2019
Medication errors involving intravenous patient-controlled analgesia: results from the 2005–2015 MEDMARX database
M Mohanty, OD Lawal, M Skeer, R Lanier, N Erpelding, N KatzTherapeutic Advances in Drug Safety 9 (8), 389-404, 2018201
12
2018

Referred From: https://scholar.google.com/citations?user=pptTpPMAAAAJ&hl=en

Cited by
Citations 22878
h-index 64
i10-index 155
Recommended Journals
Open Access Journals